212 related articles for article (PubMed ID: 8280838)
1. Immunological responses against an autologous human hepatocellular carcinoma cell line.
Usuda S; Yoshizawa K; Yabu K; Kiyosawa K
J Gastroenterol Hepatol; 1993; 8(6):517-23. PubMed ID: 8280838
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte clone specific for autologous human hepatocellular carcinoma cell line SUHC-1.
Yoshizawa K; Ota M; Kiyosawa K
J Gastroenterol Hepatol; 1998 Jan; 13(1):29-33. PubMed ID: 9737568
[TBL] [Abstract][Full Text] [Related]
3. Induction of allogeneic tumour- and lymphokine-activated lymphocytes against hepatocellular carcinoma.
Yasumura S; Higuchi K; Hioki O; Okada K; Tsukishiro T; Tsuchida T; Miyagiwa M; Nambu S; Yasuyama T; Inoue K
J Gastroenterol Hepatol; 1992; 7(2):136-41. PubMed ID: 1315167
[TBL] [Abstract][Full Text] [Related]
4. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
5. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
7. Augmented human-tumor-cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma.
Koyama S
J Cancer Res Clin Oncol; 1997; 123(9):478-84. PubMed ID: 9341896
[TBL] [Abstract][Full Text] [Related]
8. Natural and activated cytotoxic lymphocytes reactivity to human hepatocellular carcinoma cell lines in hepatocellular carcinoma patients.
Chu MH; Chien SC; Hu CP; Wang CY; Lee SD; Tsai YT; Wu JC; Han SH; Chang CM
Liver; 1988 Aug; 8(4):198-207. PubMed ID: 2843720
[TBL] [Abstract][Full Text] [Related]
9. Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma.
Ebihara T; Fukao K; Koyama S
Cancer; 1990 Sep; 66(5):923-9. PubMed ID: 2167147
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
Grant AJ; Merchant RE; Hall RE
Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
13. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
Itoh K; Platsoucas CD; Balch CM
J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
Ohta T; Kikuchi H; Ogata H; Iwata K; Yoshida K; Katayama K; Watanabe H
Cancer; 1992 Aug; 70(4):741-8. PubMed ID: 1386555
[TBL] [Abstract][Full Text] [Related]
15. Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization.
Aruga A; Yamauchi K; Takasaki K; Furukawa T; Hanyu F
Int J Cancer; 1991 Aug; 49(1):19-24. PubMed ID: 1678733
[TBL] [Abstract][Full Text] [Related]
16. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells.
Roth AD; Dupuis S; Alberto P
Clin Exp Immunol; 1995 Aug; 101(2):362-8. PubMed ID: 7648722
[TBL] [Abstract][Full Text] [Related]
18. T lymphocytes displaying major histocompatibility complex-unrestricted cytotoxicity after activation by K46M, a mitogenic monoclonal antibody against leucoagglutinin-reactive human T lymphocyte surface components.
Vargas-Cortes M; Berzins T; Hammarström ML; Hammarström S; Perlmann P
Scand J Immunol; 1987 Oct; 26(4):397-407. PubMed ID: 3500499
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific recognition of autologous leukemia cells and allogeneic class-I MHC antigens by IL-2-activated cytotoxic T cells from a patient with acute T-cell leukemia.
Fisch P; Weil-Hillman G; Uppenkamp M; Hank JA; Chen BP; Sosman JA; Bridges A; Colamonici OR; Sondel PM
Blood; 1989 Jul; 74(1):343-53. PubMed ID: 2546621
[TBL] [Abstract][Full Text] [Related]
20. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]